Back to Industry News
Medtech
Biofourmis CEO Kuldeep Singh Rajput Profiled by Forbes
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Forbes
Photo by Marcel Strauß on Unsplash
Stay updated on stories like this
Key takeaways
- Forbes highlights Kuldeep Singh Rajput, founder and CEO of Biofourmis, a Singapore-based digital therapeutics company leveraging artificial intelligence to improve outcomes for patients with complex chronic conditions
- In December 2017, the health-tech firm secured $5 million in Series A funding, led by NSI Ventures and Aviva Ventures
- Biofourmis has raised a total of $6
Forbes highlights Kuldeep Singh Rajput, founder and CEO of Biofourmis, a Singapore-based digital therapeutics company leveraging artificial intelligence to improve outcomes for patients with complex chronic conditions.
In December 2017, the health-tech firm secured $5 million in Series A funding, led by NSI Ventures and Aviva Ventures. Biofourmis has raised a total of $6.6 million to date and is currently finalizing a $50 million Series B funding round spearheaded by Sequoia Capital.
Related Topics
Biofourmisdigital therapeuticsAIchronic conditionsmedtech
Never miss stories like this